US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 108.050
  • +1.350+1.27%
Close May 13 16:00 ET
  • 108.400
  • +0.350+0.32%
Post 16:35 ET
6.77BMarket Cap-22417P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.44%-101.51M
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
-35.87%-129.89M
-87.22%-118.26M
Net income from continuing operations
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
Operating gains losses
---173.66M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
30.56%4.81M
-0.60%11.67M
-78.18%1.53M
77.17%2.87M
143.40%3.58M
126.29%3.68M
81.12%11.74M
321.89%7.02M
0.31%1.62M
-7.66%1.47M
Other non cash items
-72.18%2.37M
3,511.75%24.39M
-72.17%3.41M
167.25%11.84M
-65.52%623K
198.95%8.52M
-100.27%-715K
-95.33%12.24M
-703.18%-17.61M
-23.66%1.81M
Change In working capital
-63.52%-43.2M
23.51%-41.13M
264.99%10.4M
152.24%2.97M
-318.89%-28.08M
51.61%-26.42M
-127.07%-53.77M
-138.06%-6.31M
16.95%-5.69M
-24.59%12.83M
-Change in receivables
-250.35%-17.34M
-242.92%-7.65M
90.02%-1.7M
-142.55%-3.14M
-30.52%2.14M
-212.73%-4.95M
81.09%-2.23M
-133.12%-17.07M
-22.21%7.37M
-33.76%3.07M
-Change in inventory
3,356.41%2.7M
51.06%-4.37M
-92.93%829K
148.95%2.92M
-68.31%-8.19M
100.79%78K
28.97%-8.92M
1,666.22%11.73M
18.03%-5.96M
-1,749.49%-4.87M
-Change in prepaid assets
-93.50%1.02M
118.93%3.21M
514.89%5.66M
-658.46%-4.13M
-526.45%-13.96M
179.84%15.64M
-460.92%-16.94M
-121.01%-1.36M
171.06%739K
78.03%3.27M
-Change in payables and accrued expense
-60.66%-25.51M
-16.81%2.96M
713.82%13.81M
964.82%10.62M
-138.43%-5.6M
-110.81%-15.88M
-65.57%3.55M
-112.49%-2.25M
70.14%-1.23M
-24.10%14.56M
-Change in other current assets
-938.85%-4.33M
71.13%-4.71M
32.63%-2.99M
-123.43%-305K
-281.19%-1M
96.97%-417K
-813.77%-16.32M
-519.89%-4.43M
31.91%1.3M
114.61%553K
-Change in other current liabilities
70.50%-2.89M
-120.74%-17.87M
65.34%-2.79M
-11.58%-2.68M
-0.93%-2.6M
-297.98%-9.79M
-1.77%-8.1M
-284.09%-8.06M
-19.39%-2.4M
-4.58%-2.58M
-Change in other working capital
128.45%3.16M
-163.60%-12.69M
-115.90%-2.41M
94.25%-317K
195.70%1.14M
16.24%-11.1M
-5.04%-4.81M
1,184.05%15.14M
-91.39%-5.51M
55.96%-1.19M
Cash from discontinued investing activities
Operating cash flow
17.44%-101.51M
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
-35.87%-129.89M
-87.22%-118.26M
Investing cash flow
Cash flow from continuing investing activities
-55.36%77.13M
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
-227.06%-132.24M
166.91%77.07M
Net PPE purchase and sale
57.28%-1.1M
-80.09%-16.06M
-215.53%-4.67M
-67.63%-6.25M
0.08%-2.55M
-124.11%-2.58M
-188.73%-8.92M
-17.73%-1.48M
-274.40%-3.73M
-286.10%-2.56M
Net intangibles purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
-55.39%78.24M
306.73%290.1M
261.08%83.44M
97.40%-3.34M
-56.52%34.62M
539.13%175.38M
-496.63%-140.33M
40.83%-51.8M
-222.03%-128.22M
169.53%79.62M
Net other investing changes
----
----
----
----
----
----
---290K
---1K
----
----
Cash from discontinued investing activities
Investing cash flow
-55.36%77.13M
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
-227.06%-132.24M
166.91%77.07M
Financing cash flow
Cash flow from continuing financing activities
66.96M
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
0
1,007.76%561.81M
-86.11%2.49M
3,384.32%380.56M
1,094.95%177.5M
Net issuance payments of debt
---369K
-28.92%97.93M
-218.18%-35K
----
----
--0
--137.79M
---11K
----
----
Net common stock issuance
--48.94M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--18.4M
160.32%21.34M
521.79%15.61M
-77.60%431K
112.09%5.3M
--0
-83.84%8.2M
-86.00%2.51M
-82.38%1.92M
-83.18%2.5M
Net other financing activities
----
-100.01%-44K
----
----
----
----
--415.83M
---8K
--240.84M
----
Cash from discontinued financing activities
Financing cash flow
--66.96M
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
--0
1,007.76%561.81M
-86.11%2.49M
3,384.32%380.56M
1,094.95%177.5M
Net cash flow
Beginning cash position
-34.73%81.52M
-41.94%124.9M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-68.81%215.12M
-46.91%296.62M
-66.90%178.57M
-93.97%42.37M
Current changes in cash
-14.55%42.58M
51.58%-43.58M
108.93%15.37M
-113.23%-15.67M
-168.31%-93.11M
128.88%49.83M
81.00%-90.01M
49.82%-172.2M
510.51%118.43M
183.38%136.31M
Effect of exchange rate changes
-173.60%-145K
197.58%202K
1.88%487K
-42.74%-541K
154.13%59K
200.00%197K
76.69%-207K
194.47%478K
-208.13%-379K
32.72%-109K
End cash Position
-29.14%123.96M
-34.73%81.52M
-34.73%81.52M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-41.94%124.9M
-46.91%296.62M
-66.90%178.57M
Free cash flow
18.26%-102.62M
11.40%-452.91M
31.97%-83.6M
17.13%-110.73M
-10.11%-133.03M
6.23%-125.55M
8.70%-511.2M
55.07%-122.89M
-38.33%-133.62M
-89.28%-120.81M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.44%-101.51M13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M-35.87%-129.89M-87.22%-118.26M
Net income from continuing operations 168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M
Operating gains losses ---173.66M------------------------------------
Depreciation and amortization 30.56%4.81M-0.60%11.67M-78.18%1.53M77.17%2.87M143.40%3.58M126.29%3.68M81.12%11.74M321.89%7.02M0.31%1.62M-7.66%1.47M
Other non cash items -72.18%2.37M3,511.75%24.39M-72.17%3.41M167.25%11.84M-65.52%623K198.95%8.52M-100.27%-715K-95.33%12.24M-703.18%-17.61M-23.66%1.81M
Change In working capital -63.52%-43.2M23.51%-41.13M264.99%10.4M152.24%2.97M-318.89%-28.08M51.61%-26.42M-127.07%-53.77M-138.06%-6.31M16.95%-5.69M-24.59%12.83M
-Change in receivables -250.35%-17.34M-242.92%-7.65M90.02%-1.7M-142.55%-3.14M-30.52%2.14M-212.73%-4.95M81.09%-2.23M-133.12%-17.07M-22.21%7.37M-33.76%3.07M
-Change in inventory 3,356.41%2.7M51.06%-4.37M-92.93%829K148.95%2.92M-68.31%-8.19M100.79%78K28.97%-8.92M1,666.22%11.73M18.03%-5.96M-1,749.49%-4.87M
-Change in prepaid assets -93.50%1.02M118.93%3.21M514.89%5.66M-658.46%-4.13M-526.45%-13.96M179.84%15.64M-460.92%-16.94M-121.01%-1.36M171.06%739K78.03%3.27M
-Change in payables and accrued expense -60.66%-25.51M-16.81%2.96M713.82%13.81M964.82%10.62M-138.43%-5.6M-110.81%-15.88M-65.57%3.55M-112.49%-2.25M70.14%-1.23M-24.10%14.56M
-Change in other current assets -938.85%-4.33M71.13%-4.71M32.63%-2.99M-123.43%-305K-281.19%-1M96.97%-417K-813.77%-16.32M-519.89%-4.43M31.91%1.3M114.61%553K
-Change in other current liabilities 70.50%-2.89M-120.74%-17.87M65.34%-2.79M-11.58%-2.68M-0.93%-2.6M-297.98%-9.79M-1.77%-8.1M-284.09%-8.06M-19.39%-2.4M-4.58%-2.58M
-Change in other working capital 128.45%3.16M-163.60%-12.69M-115.90%-2.41M94.25%-317K195.70%1.14M16.24%-11.1M-5.04%-4.81M1,184.05%15.14M-91.39%-5.51M55.96%-1.19M
Cash from discontinued investing activities
Operating cash flow 17.44%-101.51M13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M-35.87%-129.89M-87.22%-118.26M
Investing cash flow
Cash flow from continuing investing activities -55.36%77.13M283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M-227.06%-132.24M166.91%77.07M
Net PPE purchase and sale 57.28%-1.1M-80.09%-16.06M-215.53%-4.67M-67.63%-6.25M0.08%-2.55M-124.11%-2.58M-188.73%-8.92M-17.73%-1.48M-274.40%-3.73M-286.10%-2.56M
Net intangibles purchase and sale ------0------------------0------------
Net investment purchase and sale -55.39%78.24M306.73%290.1M261.08%83.44M97.40%-3.34M-56.52%34.62M539.13%175.38M-496.63%-140.33M40.83%-51.8M-222.03%-128.22M169.53%79.62M
Net other investing changes ---------------------------290K---1K--------
Cash from discontinued investing activities
Investing cash flow -55.36%77.13M283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M-227.06%-132.24M166.91%77.07M
Financing cash flow
Cash flow from continuing financing activities 66.96M-78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M01,007.76%561.81M-86.11%2.49M3,384.32%380.56M1,094.95%177.5M
Net issuance payments of debt ---369K-28.92%97.93M-218.18%-35K----------0--137.79M---11K--------
Net common stock issuance --48.94M------------------0----------------
Proceeds from stock option exercised by employees --18.4M160.32%21.34M521.79%15.61M-77.60%431K112.09%5.3M--0-83.84%8.2M-86.00%2.51M-82.38%1.92M-83.18%2.5M
Net other financing activities -----100.01%-44K------------------415.83M---8K--240.84M----
Cash from discontinued financing activities
Financing cash flow --66.96M-78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M--01,007.76%561.81M-86.11%2.49M3,384.32%380.56M1,094.95%177.5M
Net cash flow
Beginning cash position -34.73%81.52M-41.94%124.9M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-68.81%215.12M-46.91%296.62M-66.90%178.57M-93.97%42.37M
Current changes in cash -14.55%42.58M51.58%-43.58M108.93%15.37M-113.23%-15.67M-168.31%-93.11M128.88%49.83M81.00%-90.01M49.82%-172.2M510.51%118.43M183.38%136.31M
Effect of exchange rate changes -173.60%-145K197.58%202K1.88%487K-42.74%-541K154.13%59K200.00%197K76.69%-207K194.47%478K-208.13%-379K32.72%-109K
End cash Position -29.14%123.96M-34.73%81.52M-34.73%81.52M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-41.94%124.9M-46.91%296.62M-66.90%178.57M
Free cash flow 18.26%-102.62M11.40%-452.91M31.97%-83.6M17.13%-110.73M-10.11%-133.03M6.23%-125.55M8.70%-511.2M55.07%-122.89M-38.33%-133.62M-89.28%-120.81M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.44%